Effect of Silver Diamine Fluoride on Local Anesthesia in Hypomineralized Molars
1 other identifier
interventional
50
1 country
1
Brief Summary
The purpose of this randomized, controlled clinical study is to evaluate if application of 38% SDF increases the efficacy of local anesthesia during operative dentistry on permanent molars affected by molar-incisor hypoplasia (MIH). The goal is to determine if pre-operative application of SDF results in improved local anesthesia and decrease in procedural pain in MIH affected teeth, thereby addressing an important challenge in routine clinical practice and contributing to the development of a treatment protocol for MIH affected molars.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2023
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 12, 2023
CompletedFirst Submitted
Initial submission to the registry
July 18, 2023
CompletedFirst Posted
Study publicly available on registry
July 27, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2027
February 12, 2026
February 1, 2026
4.6 years
July 18, 2023
February 9, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Sixou and Barbosa-Rogier scale for local anesthesia efficacy
Four point scale evaluating efficacy of local anesthesia
At least two weeks following application of SDF or placebo on the enrolled tooth
Secondary Outcomes (1)
Schiff Cold Air Sensitivity Scale
At least two weeks following application of SDF or placebo on the enrolled tooth
Other Outcomes (1)
Face, Legs, Activity, Cry, Consolability (FLACC) Scale
At least two weeks following application of SDF or placebo on the enrolled tooth
Study Arms (2)
SDF
EXPERIMENTAL38% SDF applied to hypomineralized permanent molar two weeks prior to restorative care of the tooth.
Placebo
PLACEBO COMPARATORInert liquid (colored water) applied to hypomineralized permanent molar two weeks prior to restorative care of the tooth.
Interventions
Eligibility Criteria
You may qualify if:
- At least one hypomineralized first permanent molar with a primary cavitated caries lesion(s) or a cavitated tooth defect requiring restorative dental care with local anesthesia
- American Society of Anesthesiologists (ASA) Physical Status Classification I or II (healthy children or those with mild systemic disease)
- English speaking
- Subjects for which basic behavior guidance (non-pharmacological or nitrous oxide/oxygen) is indicated
You may not qualify if:
- Teeth with irreversible pulpitis and pulp necrosis
- Patients requiring advanced behavior management such as moderate sedation, general anesthesia, and/or active or passive restraint
- Inability of the child to cooperate due to special needs or other conditions
- Allergy to SDF, local anesthetic or other material component
- Subjects with ulcerative gingivitis or stomatitis
- Subjects with known sensitivity to silver or other heavy-metal ions
- Subjects showing abnormal skin sensitization in daily circumstances
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Michigan
Ann Arbor, Michigan, 48109, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
James Boynton, DDS
University of Michigan
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- The subject, care provider/outcomes assessor, and investigator will be blinded to which arm the tooth is randomized.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Professor
Study Record Dates
First Submitted
July 18, 2023
First Posted
July 27, 2023
Study Start
June 12, 2023
Primary Completion (Estimated)
December 31, 2027
Study Completion (Estimated)
December 31, 2027
Last Updated
February 12, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will not share
Individual Participant Data (IPD) is not planned to be shared.